Amylases Market Segments - by Product Type (Bacterial Amylases, Fungal Amylases, Plant-Derived Amylases, Animal-Derived Amylases, and Engineered Amylases), Application (Food & Beverages, Pharmaceuticals, Textile, Paper & Pulp, and Others), Distribution Channel (Direct Sales, Indirect Sales), Form (Liquid Amylases, Powder Amylases), Source (Microbial Amylases, Plant Amylases, Animal Amylases), and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2025-2035

Amylases Sales

Amylases Market Segments - by Product Type (Bacterial Amylases, Fungal Amylases, Plant-Derived Amylases, Animal-Derived Amylases, and Engineered Amylases), Application (Food & Beverages, Pharmaceuticals, Textile, Paper & Pulp, and Others), Distribution Channel (Direct Sales, Indirect Sales), Form (Liquid Amylases, Powder Amylases), Source (Microbial Amylases, Plant Amylases, Animal Amylases), and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2025-2035

Amylases Sales Market Outlook

The global amylases market is projected to reach an estimated value of approximately USD 6 billion by 2035, growing at a robust compound annual growth rate (CAGR) of around 6% during the forecast period from 2025 to 2035. This growth is primarily driven by the increasing demand for amylases in various industries such as food and beverages, pharmaceuticals, and textiles. The rising popularity of enzymes as a natural alternative to chemical processes has further bolstered the market growth. Additionally, the growing awareness about the benefits of microbial enzymes in enhancing production efficiency and reducing waste is also contributing significantly to market expansion. Moreover, the adoption of advanced technologies in enzyme production is expected to create new opportunities for manufacturers, positioning the amylases market for substantial growth in the coming years.

Growth Factor of the Market

The amylases market is experiencing significant growth due to various factors that are reshaping consumer preferences and industrial practices. One of the primary drivers is the increasing demand for high-quality food products, which has led food manufacturers to incorporate amylases to improve texture, flavor, and shelf life. Additionally, the expansion of the pharmaceutical sector is fueling the need for amylases in drug formulation, enhancing product efficacy and bioavailability. Environmental concerns regarding traditional chemical processes have also prompted industries to seek eco-friendly alternatives like amylases, which are biodegradable and less harmful to the environment. Furthermore, advancements in biotechnology and enzyme engineering are facilitating the development of more efficient and cost-effective amylases, catering to diverse applications. These growth factors collectively underscore the potential of the amylases market to thrive in the coming years.

Key Highlights of the Market
  • Projected market value of approximately USD 6 billion by 2035, with a CAGR of 6%.
  • Growing demand in food and beverage, pharmaceuticals, and textile industries.
  • Increased focus on sustainable and eco-friendly enzyme solutions.
  • Advancements in biotechnology and enzyme engineering enhancing product efficiency.
  • Rising consumer awareness regarding the health benefits of enzymes in food production.

By Product Type

Bacterial Amylases:

Bacterial amylases are one of the most widely used enzymes in various industrial applications. These enzymes are produced through fermentation processes using specific strains of bacteria. Due to their robustness and effectiveness at high temperatures, bacterial amylases are particularly favored in the food industry for starch hydrolysis, enhancing the sweetness and texture of products such as syrups, candies, and baked goods. Moreover, their versatility allows for applications in brewing and distilling processes, contributing to alcohol production efficiency. As food manufacturers strive for cleaner labels, the use of naturally derived bacterial amylases presents a compelling solution, further driving their market demand.

Fungal Amylases:

Fungal amylases, derived from specific fungi strains, are another significant segment of the amylases market. These enzymes are particularly effective in acidic environments, making them suitable for various applications in the food and beverage sector, especially in the production of fermented foods. Fungal amylases aid in saccharification processes, improving the conversion of starch to sugars, which is crucial in the brewing and baking industries. Additionally, the growing trend of plant-based diets has led to an increased usage of fungal amylases in gluten-free products, as they help enhance texture and flavor. The rising demand for healthier food options is expected to further boost the market for fungal amylases in the coming years.

Plant-Derived Amylases:

Plant-derived amylases are gaining attention due to the increasing preference for natural and organic products. Extracted from various plant sources, these enzymes are particularly sought after in the food industry for their ability to enhance flavor and nutritional value. They play a vital role in the digestion and metabolism of carbohydrates, making them essential for health-focused formulations. The demand for plant-derived amylases is also supported by the growth of the health and wellness trend, as consumers seek products with functional benefits. Furthermore, their application in the textile industry for starch removal from fabrics positions them as a versatile choice across different sectors.

Animal-Derived Amylases:

Animal-derived amylases, although less prevalent than microbial options, still hold a notable position in the market. These enzymes are typically sourced from animal organs or tissues and can be used in various applications, particularly in the food and pharmaceutical industries. They are recognized for their effectiveness in starch digestion and are often utilized in specific therapeutic formulations. The demand for animal-derived amylases is expected to remain steady, however, there is a growing consumer preference for vegetarian and vegan products, which may limit the growth of this segment in the long run.

Engineered Amylases:

Engineered amylases represent a cutting-edge segment in the amylases market. Through genetic engineering and biotechnology, these enzymes have been designed to enhance their stability, activity, and specificity, making them suitable for various industrial applications. The ability to tailor amylases to meet the specific requirements of different processes is driving their adoption in industries such as food, beverages, and pharmaceuticals. As manufacturers seek to optimize production processes and improve efficiency, the demand for engineered amylases is expected to increase significantly, pushing the boundaries of enzyme technology.

By Application

Food & Beverages:

The food and beverage sector is the largest application area for amylases, accounting for a significant share of the market. Amylases are integral to various processes including starch conversion, brewing, and baking. Their role in enhancing the sweetness, texture, and shelf life of products is vital to meeting consumer expectations and regulatory standards. As the global population continues to grow and dietary preferences evolve, the demand for diverse food products is driving the need for efficient enzymatic processes. Innovations in food technology and the introduction of clean-label products are expected to further boost the utilization of amylases in this sector.

Pharmaceuticals:

The use of amylases in the pharmaceutical industry is expanding as they play a vital role in drug formulation and delivery. These enzymes are utilized in the production of oral dosage forms, where they aid in the digestion and absorption of active pharmaceutical ingredients. The increasing focus on personalized medicine and the development of novel drug delivery systems are anticipated to elevate the demand for amylases in pharmaceuticals. Additionally, as the healthcare sector grows, the need for efficient and effective excipients in drug formulation will drive the market for amylases in this application.

Textile:

Amylases are increasingly being used in the textile industry for various applications, including starch removal and fabric finishing. The enzymatic process allows for more environmentally friendly treatments compared to traditional chemical methods, thereby aligning with the industry's shift towards sustainability. As consumers demand high-quality fabrics with improved texture and appearance, the application of amylases in textile processing is becoming more prevalent. This segment is expected to grow as manufacturers continue to explore eco-friendly solutions in fabric processing.

Paper & Pulp:

The paper and pulp industry is another significant user of amylases, where they are employed to enhance starch adhesion and improve the quality of paper products. The use of amylases in this sector supports the development of paper with better strength and printability while minimizing the environmental impact of production processes. As the global demand for sustainable paper products grows, the integration of amylases in pulp and paper manufacturing is anticipated to rise, driven by the need for efficient and eco-friendly production methods.

Others:

In addition to the primary applications, amylases find usage in various other sectors including biofuels, animal feed, and personal care products. In biofuel production, amylases assist in breaking down starches into fermentable sugars, thereby improving ethanol yields. The incorporation of amylases in animal feed enhances nutrient absorption, contributing to better livestock health and productivity. Furthermore, the cosmetic industry is exploring the use of amylases in formulations aimed at improving skin texture and moisture retention. The diverse applications of amylases beyond the conventional sectors highlight their versatility and potential for market expansion.

By Distribution Channel

Direct Sales:

Direct sales channels for amylases involve manufacturers selling their products directly to end-users, which can include large-scale food processors, pharmaceutical companies, and textile manufacturers. This approach allows companies to establish closer relationships with their customers, ensuring tailored solutions that meet specific needs. Moreover, direct sales often provide better pricing structures and the ability to offer technical support and enhanced service levels. As customer demands continue to diversify, the importance of direct sales channels in the amylases market is expected to grow, allowing manufacturers to adapt quickly to changing market conditions.

Indirect Sales:

Indirect sales of amylases encompass distribution through intermediaries such as wholesalers, distributors, and retailers. This channel enables manufacturers to reach a broader customer base and penetrate various regions more effectively. By leveraging established networks, companies can efficiently distribute their products to various market segments, including small and medium-sized enterprises that may not have direct access to manufacturers. The reliance on indirect sales channels is likely to remain significant as the demand for amylases continues to grow globally, providing essential support to manufacturers in reaching diverse applications.

By Form

Liquid Amylases:

Liquid amylases are widely utilized due to their ease of application and versatility across different industries. They are particularly favored in the food and beverage sector where they can be easily integrated into production processes such as brewing and baking. Liquid forms allow for precise dosing and can be easily mixed with other ingredients, enhancing their effectiveness in starch hydrolysis. The convenience and efficiency of liquid amylases in various applications position them as a preferred choice, driving their market growth. As manufacturers focus on optimizing production processes, the demand for liquid amylases is expected to rise.

Powder Amylases:

Powder amylases are another important form in the market, valued for their stability and longer shelf life compared to liquid forms. They are particularly popular in the textile and paper industries, where they can be stored and transported more easily. Powder amylases are often preferred in situations where a longer storage period is required or where specific formulations are needed. The development of new formulations and techniques to enhance the solubility of powder amylases is anticipated to further boost their adoption across various applications, contributing to the overall growth of the amylases market.

By Source

Microbial Amylases:

Microbial amylases are derived from microorganisms such as bacteria and fungi, making them the most commercially significant type in the market. These enzymes are favored due to their high efficiency, stability, and ability to function in diverse conditions, such as extreme temperatures and pH levels. Their widespread application in food processing, pharmaceuticals, and textiles underscores their importance in modern industrial practices. As the demand for enzymatic solutions continues to rise, microbial amylases will remain at the forefront, driven by innovations in biotechnology that enhance their performance and applications.

Plant Amylases:

Plant amylases, extracted from various plant sources, are increasingly recognized for their natural and eco-friendly properties. They play a crucial role in the food industry, especially in the production of health-focused products. The growing trend towards plant-based diets and natural ingredients is expected to propel the demand for plant amylases. Their application in various sectors, combined with the consumer preference for clean label products, positions plant amylases as a valuable alternative to microbial and animal-derived options, further contributing to their market growth.

Animal Amylases:

Although animal amylases have a smaller market share compared to microbial sources, they are still utilized in certain applications, particularly in pharmaceuticals and specialty food products. Their effectiveness in specific formulations offers advantages in certain therapeutic contexts. However, the increasing trend towards vegetarian and plant-based products may pose challenges for the growth of animal amylases in the long term. Nonetheless, they maintain a niche market, especially where traditional methods are preferred, allowing for specialized applications that may not be easily replaced by other types.

By Region

North America is anticipated to dominate the amylases market, attributed to the presence of advanced food processing industries and a robust pharmaceutical sector. The region accounted for approximately 35% of the global market share in 2025, with a projected CAGR of 5.5% through 2035. The increasing adoption of enzymatic solutions in food manufacturing and pharmaceuticals, along with a strong focus on research and development, are key factors driving growth in this region. Furthermore, growing consumer awareness regarding health and wellness products supports the demand for natural ingredients, including amylases.

Europe is another significant region in the amylases market, contributing around 30% of the global share in 2025. The region's growth is primarily driven by the increasing demand for high-quality food products and advancements in enzyme technology. As the food industry continues to evolve and consumers become more health-conscious, the use of amylases in food processing is expected to grow. Additionally, the pharmaceutical and textile sectors are also key contributors to the market in Europe, providing a diverse base for amylase applications. The CAGR for the European market is projected to be around 5% during the forecast period.

Opportunities

The amylases market is poised for significant opportunities as industries continue to shift towards sustainable and eco-friendly practices. The increasing emphasis on reducing environmental impact is prompting manufacturers to seek natural alternatives to chemical processes. Amylases present a viable solution, as they are biodegradable and have a lower carbon footprint compared to traditional methods. Additionally, the growing trend of health and wellness among consumers is driving demand for clean-label products, which further supports the incorporation of amylases in food formulations. As consumers become more conscious of ingredient sourcing and sustainability, companies that prioritize the use of natural enzymes are likely to gain competitive advantages, leading to expanded market share and profitability.

Furthermore, advancements in biotechnology and genetic engineering are creating opportunities for the development of more efficient and tailored amylases to meet specific industry needs. As manufacturers continue to innovate, they can produce enzymes with enhanced stability, activity, and specificity, catering to diverse applications across various sectors. The expansion of emerging markets, coupled with the growth of e-commerce platforms, provides additional avenues for reaching new customers and enhancing distribution channels. These factors collectively position the amylases market for robust growth and innovation, paving the way for new entrants and established players to capitalize on evolving industry trends.

Threats

The amylases market faces several threats that could potentially hinder its growth trajectory. One of the primary challenges is the increasing competition from synthetic alternatives that promise similar efficiency at lower costs. As industries continue to prioritize cost-effective solutions, the adoption of chemically synthesized enzymes may pose a threat to the market share of natural amylases. Additionally, fluctuations in raw material availability and prices can impact production costs and pricing strategies for manufacturers. Supply chain disruptions caused by geopolitical tensions or natural disasters may also affect the timely distribution of amylases to end-users, causing potential delays and loss of market competitiveness.

Moreover, regulatory hurdles and stringent quality standards in various regions can pose challenges for manufacturers in the amylases market. Compliance with these regulations requires significant investments in research and development, as well as adherence to safety and efficacy standards. Companies that fail to meet these requirements may find it difficult to penetrate certain markets, limiting their growth potential. The evolving landscape of consumer preferences, along with increasing awareness around environmental and health issues, necessitates continuous adaptation and innovation. Failure to keep pace with these changes could result in a loss of market relevance and decreased consumer trust.

Competitor Outlook

  • Novozymes A/S
  • DSM (Royal DSM)
  • DuPont de Nemours, Inc.
  • Associated British Foods plc (ABF Ingredients)
  • BASF SE
  • Hayashi Pure Chemical Industries, Ltd.
  • Roche Holding AG
  • Kemin Industries, Inc.
  • Enzyme Development Corporation
  • Amano Enzyme Inc.
  • Genencor International, Inc.
  • AB Enzymes GmbH
  • Biocatalysts Ltd.
  • Verenium Corporation
  • Solvay SA

The competitive landscape of the amylases market is characterized by the presence of several key players who leverage technological advancements and innovation to maintain their market positions. Leading companies like Novozymes A/S and DSM dominate the market with their extensive portfolios of enzyme products and robust R&D capabilities. These companies continuously invest in research to develop new enzyme formulations that cater to the evolving needs of various industries, ensuring they stay ahead of the competition. Moreover, strategic partnerships and collaborations with other companies and research institutions allow them to enhance their product offerings and expand their market reach.

Furthermore, smaller and emerging players are also gaining traction by focusing on niche markets and offering specialized enzyme products tailored to specific applications. This diversification of product offerings creates a competitive market environment, pushing established companies to innovate and improve their existing products constantly. Additionally, the trend towards sustainability has prompted many companies to invest in the development of eco-friendly and biodegradable enzymes, aligning their product offerings with consumer preferences for natural ingredients. As the market continues to evolve, companies that prioritize innovation, sustainability, and customer-centric approaches are likely to thrive in the competitive landscape of the amylases market.

Among the major players, Novozymes A/S stands out as a global leader in enzyme production, offering a wide range of amylases for various applications across the food, beverage, and pharmaceutical sectors. With a strong emphasis on research and development, Novozymes continuously seeks to optimize enzyme performance and develop innovative solutions that cater to the specific needs of its customers. The company's commitment to sustainability is evident in its efforts to produce enzymes that reduce environmental impact and enhance production efficiency, positioning it as a preferred choice among manufacturers seeking eco-friendly solutions.

Another significant player, DSM (Royal DSM), combines enzymology and biotechnology to develop high-quality amylases that enhance product performance across industries. With a focus on innovation and sustainability, DSM invests heavily in R&D to create enzyme products that meet the highest quality standards. The company's extensive experience in enzyme applications and commitment to addressing market trends ensure its strong competitive position in the amylases market. Additionally, BASF SE and DuPont de Nemours, Inc. leverage their vast resources and expertise to develop advanced enzymatic solutions, further contributing to the competitive dynamics of the market.

  • 1 Appendix
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 Market Definition
    • 2.2 Scope of the Report
    • 2.3 Study Assumptions
    • 2.4 Base Currency & Forecast Periods
  • 3 Market Dynamics
    • 3.1 Market Growth Factors
    • 3.2 Economic & Global Events
    • 3.3 Innovation Trends
    • 3.4 Supply Chain Analysis
  • 4 Consumer Behavior
    • 4.1 Market Trends
    • 4.2 Pricing Analysis
    • 4.3 Buyer Insights
  • 5 Key Player Profiles
    • 5.1 BASF SE
      • 5.1.1 Business Overview
      • 5.1.2 Products & Services
      • 5.1.3 Financials
      • 5.1.4 Recent Developments
      • 5.1.5 SWOT Analysis
    • 5.2 Solvay SA
      • 5.2.1 Business Overview
      • 5.2.2 Products & Services
      • 5.2.3 Financials
      • 5.2.4 Recent Developments
      • 5.2.5 SWOT Analysis
    • 5.3 Novozymes A/S
      • 5.3.1 Business Overview
      • 5.3.2 Products & Services
      • 5.3.3 Financials
      • 5.3.4 Recent Developments
      • 5.3.5 SWOT Analysis
    • 5.4 AB Enzymes GmbH
      • 5.4.1 Business Overview
      • 5.4.2 Products & Services
      • 5.4.3 Financials
      • 5.4.4 Recent Developments
      • 5.4.5 SWOT Analysis
    • 5.5 DSM (Royal DSM)
      • 5.5.1 Business Overview
      • 5.5.2 Products & Services
      • 5.5.3 Financials
      • 5.5.4 Recent Developments
      • 5.5.5 SWOT Analysis
    • 5.6 Roche Holding AG
      • 5.6.1 Business Overview
      • 5.6.2 Products & Services
      • 5.6.3 Financials
      • 5.6.4 Recent Developments
      • 5.6.5 SWOT Analysis
    • 5.7 Amano Enzyme Inc.
      • 5.7.1 Business Overview
      • 5.7.2 Products & Services
      • 5.7.3 Financials
      • 5.7.4 Recent Developments
      • 5.7.5 SWOT Analysis
    • 5.8 Biocatalysts Ltd.
      • 5.8.1 Business Overview
      • 5.8.2 Products & Services
      • 5.8.3 Financials
      • 5.8.4 Recent Developments
      • 5.8.5 SWOT Analysis
    • 5.9 Verenium Corporation
      • 5.9.1 Business Overview
      • 5.9.2 Products & Services
      • 5.9.3 Financials
      • 5.9.4 Recent Developments
      • 5.9.5 SWOT Analysis
    • 5.10 Kemin Industries, Inc.
      • 5.10.1 Business Overview
      • 5.10.2 Products & Services
      • 5.10.3 Financials
      • 5.10.4 Recent Developments
      • 5.10.5 SWOT Analysis
    • 5.11 DuPont de Nemours, Inc.
      • 5.11.1 Business Overview
      • 5.11.2 Products & Services
      • 5.11.3 Financials
      • 5.11.4 Recent Developments
      • 5.11.5 SWOT Analysis
    • 5.12 Genencor International, Inc.
      • 5.12.1 Business Overview
      • 5.12.2 Products & Services
      • 5.12.3 Financials
      • 5.12.4 Recent Developments
      • 5.12.5 SWOT Analysis
    • 5.13 Enzyme Development Corporation
      • 5.13.1 Business Overview
      • 5.13.2 Products & Services
      • 5.13.3 Financials
      • 5.13.4 Recent Developments
      • 5.13.5 SWOT Analysis
    • 5.14 Hayashi Pure Chemical Industries, Ltd.
      • 5.14.1 Business Overview
      • 5.14.2 Products & Services
      • 5.14.3 Financials
      • 5.14.4 Recent Developments
      • 5.14.5 SWOT Analysis
    • 5.15 Associated British Foods plc (ABF Ingredients)
      • 5.15.1 Business Overview
      • 5.15.2 Products & Services
      • 5.15.3 Financials
      • 5.15.4 Recent Developments
      • 5.15.5 SWOT Analysis
  • 6 Market Segmentation
    • 6.1 Amylases Sales Market, By Form
      • 6.1.1 Liquid Amylases
      • 6.1.2 Powder Amylases
    • 6.2 Amylases Sales Market, By Source
      • 6.2.1 Microbial Amylases
      • 6.2.2 Plant Amylases
      • 6.2.3 Animal Amylases
    • 6.3 Amylases Sales Market, By Application
      • 6.3.1 Food & Beverages
      • 6.3.2 Pharmaceuticals
      • 6.3.3 Textile
      • 6.3.4 Paper & Pulp
      • 6.3.5 Others
    • 6.4 Amylases Sales Market, By Product Type
      • 6.4.1 Bacterial Amylases
      • 6.4.2 Fungal Amylases
      • 6.4.3 Plant-Derived Amylases
      • 6.4.4 Animal-Derived Amylases
      • 6.4.5 Engineered Amylases
    • 6.5 Amylases Sales Market, By Distribution Channel
      • 6.5.1 Direct Sales
      • 6.5.2 Indirect Sales
  • 7 Competitive Analysis
    • 7.1 Key Player Comparison
    • 7.2 Market Share Analysis
    • 7.3 Investment Trends
    • 7.4 SWOT Analysis
  • 8 Research Methodology
    • 8.1 Analysis Design
    • 8.2 Research Phases
    • 8.3 Study Timeline
  • 9 Future Market Outlook
    • 9.1 Growth Forecast
    • 9.2 Market Evolution
  • 10 Geographical Overview
    • 10.1 Europe - Market Analysis
      • 10.1.1 By Country
        • 10.1.1.1 UK
        • 10.1.1.2 France
        • 10.1.1.3 Germany
        • 10.1.1.4 Spain
        • 10.1.1.5 Italy
    • 10.2 Asia Pacific - Market Analysis
      • 10.2.1 By Country
        • 10.2.1.1 India
        • 10.2.1.2 China
        • 10.2.1.3 Japan
        • 10.2.1.4 South Korea
    • 10.3 Amylases Sales Market by Region
    • 10.4 Latin America - Market Analysis
      • 10.4.1 By Country
        • 10.4.1.1 Brazil
        • 10.4.1.2 Argentina
        • 10.4.1.3 Mexico
    • 10.5 North America - Market Analysis
      • 10.5.1 By Country
        • 10.5.1.1 USA
        • 10.5.1.2 Canada
    • 10.6 Middle East & Africa - Market Analysis
      • 10.6.1 By Country
        • 10.6.1.1 Middle East
        • 10.6.1.2 Africa
  • 11 Global Economic Factors
    • 11.1 Inflation Impact
    • 11.2 Trade Policies
  • 12 Technology & Innovation
    • 12.1 Emerging Technologies
    • 12.2 AI & Digital Trends
    • 12.3 Patent Research
  • 13 Investment & Market Growth
    • 13.1 Funding Trends
    • 13.2 Future Market Projections
  • 14 Market Overview & Key Insights
    • 14.1 Executive Summary
    • 14.2 Key Trends
    • 14.3 Market Challenges
    • 14.4 Regulatory Landscape
Segments Analyzed in the Report
The global Amylases Sales market is categorized based on
By Product Type
  • Bacterial Amylases
  • Fungal Amylases
  • Plant-Derived Amylases
  • Animal-Derived Amylases
  • Engineered Amylases
By Application
  • Food & Beverages
  • Pharmaceuticals
  • Textile
  • Paper & Pulp
  • Others
By Distribution Channel
  • Direct Sales
  • Indirect Sales
By Form
  • Liquid Amylases
  • Powder Amylases
By Source
  • Microbial Amylases
  • Plant Amylases
  • Animal Amylases
By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key Players
  • Novozymes A/S
  • DSM (Royal DSM)
  • DuPont de Nemours, Inc.
  • Associated British Foods plc (ABF Ingredients)
  • BASF SE
  • Hayashi Pure Chemical Industries, Ltd.
  • Roche Holding AG
  • Kemin Industries, Inc.
  • Enzyme Development Corporation
  • Amano Enzyme Inc.
  • Genencor International, Inc.
  • AB Enzymes GmbH
  • Biocatalysts Ltd.
  • Verenium Corporation
  • Solvay SA
  • Publish Date : Jan 20 ,2025
  • Report ID : CH-15215
  • No. Of Pages : 100
  • Format : |
  • Ratings : 4.5 (110 Reviews)
Buy Report
Buy Report
Connect With Us
What Our Client Say